
FILE PHOTO: People walk near a Baidu logo at the company headquarters in Beijing, China April 23, 2021. REUTERS/Florence Lo
BEIJING (Reuters) - Chinese tech giant Baidu Inc said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.
Sanofi had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech/Pfizer and Moderna in developing mRNA shots against COVID-19.
Already a subscriber? Log in
Subscribe now and get 30% off The Star Yearly Plan
Cancel anytime. Ad-free. Unlimited access with perks.